Creating new models to study vision loss and cell therapy for eye diseases
A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy
This study is exploring new ways to help people with inherited eye diseases like retinitis pigmentosa and Leber congenital amaurosis by creating models to understand how vision loss happens and how we might replace damaged cells to improve sight.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10925321 on NIH RePORTER |
What this research studies
This research focuses on inherited retinal diseases like retinitis pigmentosa and Leber congenital amaurosis, which lead to severe vision impairment. The team is developing innovative models to better understand how photoreceptors degenerate and how to replace them using advanced cell therapy techniques. By utilizing a combination of laser-induced damage and cutting-edge genome-editing technology, they aim to create effective models that can help evaluate the survival and integration of transplanted photoreceptor cells. This approach could provide insights into potential treatments for patients suffering from these debilitating eye conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with inherited retinal diseases, particularly those experiencing severe vision loss.
Not a fit: Patients with retinal diseases that are not inherited or those with mild vision impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that restore vision for patients with inherited retinal diseases.
How similar studies have performed: Previous studies have shown promise in using cell replacement therapies for retinal degeneration, indicating that this approach has potential for success.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Fu, Yingbin — Baylor College of Medicine
- Study coordinator: Fu, Yingbin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.